The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
Abstract Background Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are generally ignored. To explore alternative treatment options, we studied the e...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-02-01
|
| Series: | BMC Cancer |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12885-024-11921-7 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|